Gamida Cell closes $40mm Series F round

15:40 EDT 20 Jun 2017 | Elsevier Business Intelligence

Gamida Cell Ltd. (cell and immunotherapies for cancer) raised $40mm through what appears to be its Series F round. (The fundi...

Original Article: Gamida Cell closes $40mm Series F round


More From BioPortfolio on "Gamida Cell closes $40mm Series F round"

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...